Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Piantoni

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|March 4, 2014
Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritisMirko Scarsi, Lucia Paolini, Doris Ricotta, et al.
Clinical and Experimental Rheumatology|January 27, 2022
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abataceptStefania Masneri, Silvia Piantoni, Giorgio Galoppini, et al.
Current Rheumatology Reports|June 12, 2013
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodiesLaura Andreoli, Micaela Fredi, Cecilia Nalli, et al.
Clinical and Experimental Medicine|March 29, 2025
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single centerIlaria Cavazzana, Paolo Semeraro, Cesare Tomasi, et al.
Blood Reviews|September 2, 2020
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation systemMaria Grazia Lazzaroni, Silvia Piantoni, Stefania Masneri, et al.
Clinical Rheumatology|June 22, 2020
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et alSilvia Piantoni, Enrico Colombo, Paolo Airò, et al.
Bioanalysis|August 16, 2023
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatmentAlessia Caproli, Silvia Della Pina, Marika Vezzoli, et al.
Clinical and Experimental Rheumatology|May 3, 2020
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abataceptRajesh Kumar, Silvia Piantoni, Michele Boldini, et al.
Frontiers in Pharmacology|June 7, 2021
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapySilvia Piantoni, Francesca Regola, Stefania Masneri, et al.
Journal of Medical Virology|January 29, 2021
Reports of three long-term lung disease following SARS-CoV-2 infectionSilvia Piantoni, Luisa Salada, Enrico Colombo, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|March 4, 2014
Abatacept reduces levels of switched memory B cells, autoantibodies, and immunoglobulins in patients with rheumatoid arthritisMirko Scarsi, Lucia Paolini, Doris Ricotta, et al.
Clinical and Experimental Rheumatology|January 27, 2022
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abataceptStefania Masneri, Silvia Piantoni, Giorgio Galoppini, et al.
Current Rheumatology Reports|June 12, 2013
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodiesLaura Andreoli, Micaela Fredi, Cecilia Nalli, et al.
Clinical and Experimental Medicine|March 29, 2025
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single centerIlaria Cavazzana, Paolo Semeraro, Cesare Tomasi, et al.
Blood Reviews|September 2, 2020
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation systemMaria Grazia Lazzaroni, Silvia Piantoni, Stefania Masneri, et al.
Clinical Rheumatology|June 22, 2020
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et alSilvia Piantoni, Enrico Colombo, Paolo Airò, et al.
Bioanalysis|August 16, 2023
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatmentAlessia Caproli, Silvia Della Pina, Marika Vezzoli, et al.
Clinical and Experimental Rheumatology|May 3, 2020
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abataceptRajesh Kumar, Silvia Piantoni, Michele Boldini, et al.
Frontiers in Pharmacology|June 7, 2021
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of TherapySilvia Piantoni, Francesca Regola, Stefania Masneri, et al.
Journal of Medical Virology|January 29, 2021
Reports of three long-term lung disease following SARS-CoV-2 infectionSilvia Piantoni, Luisa Salada, Enrico Colombo, et al.
Pageof 7